dexfenfluramine marketed dexfenfluramine hydrochloride name redux serotonergic anorectic drug reduces appetite increasing amount extracellular serotonin denantiomer fenfluramine structurally similar amphetamine lacks psychologically stimulating effects dexfenfluramine years approved united states food drug administration purposes weight loss however following multiple concerns cardiovascular sideeffects fda withdrew approval removed us dexfenfluramine also pulled global markets later superseded sibutramine although initially considered safer alternative dexfenfluramine likewise removed us market drug developed interneuron pharmaceuticals company cofounded richard wurtman aimed marketing discoveries massachusetts institute technology interneuron licensed patent wyethayerst although time release optimism prevailed might herald new remained reservations amongst neurologists twentytwo petitioned fda delay approvalcitation needed concern based work george ricaurte whose techniques conclusions later stimulants phenylethanolamine httpsenwikipediaorgwikidexfenfluramine